Skip to main navigation
Skip to search
Skip to main content
Monash University Home
Help & FAQ
Home
Profiles
Research units
Equipment
Projects
Research output
Prizes
Activities
Press/Media
Search by expertise, name or affiliation
Phase 3 randomized double-blind controlled trial of Cabozantinib (XL 184) vs Mitoxantrone plus Prednisone in men with previously treated symptomatic castration-resistant prostate cance (XL 184-306)
Parente, Phillip
(Primary Chief Investigator (PCI))
Eastern Health Clinical School
Project
:
Research
Overview
Project Details
Status
Finished
Effective start/end date
1/05/13
→
30/11/13
View all
View less